Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for NEVANAC
- A Study of the Effect of Different Doses of Difluprednate Eye Drops on the Intraocular Pressure After Phacoemulsification
- Metabolomic Profile in Dry Eye Syndrome Patients.
- PGE2 Levels in Patient Treated With NSAIDs
- Efficacy and Necessity of Anti-inflammatory Drops After Laser Peripheral Iridotomy
- Topical Nepafenac as Supplement for Diabetic Macular Edema
- Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification
- Effect of Nepafenac Eye Drops on Intraocular Pressure in Normal Eyes
- Macular Edema Nepafenac vs. Difluprednate Uveitis Trial
- Efficacy and Safety of PRO-155 Versus Nevanac in Post Phacoemulsification
- Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy
- Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%
- A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification
- A Comparison of Peak Aqueous Penetration of Acuvail (Ketorolac 0.45%), Xibrom (Bromfenac 0.09%), and Nevanac (Nepafenac 0.1%)in Patients Undergoing Phacoemulsification
- Macular Edema Incidence/Severity Reduction With Nevanac
- Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema
- Comparison of Pain Sensation During Single Use of Two Topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Effect of Anti-inflammatory Topical Prednisolone, Nepafenac and Ketorolac in Intra-operative Mydriasis in Facetectomies
- Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)
- A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients
- Efficacy Study of Triamcinolone Associated With Nepafenac for Treatment of Diabetic Macular Edema
- Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%
- Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery
- Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRK
- Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery
- Nevanac 3-Month Safety Study With QID Dosing
Clinical trials list
click for details